Antibody cocktail from Eli Lilly showing promise to reduce effects of COVID-19
Eli Lilly says its new antibody cocktail could greatly reduce hospitalizations and deaths for high-risk COVID-19 patients. Their new drug bamlanivimab when combined with the...
